Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Neupogen

Filgrastim Neupogen GCSF Neutrophil 5 mcg/kg per day SQ or IV or round to 300- or 480-mcg vial size Bone pain (approximately 25%) Begin 1-3 days after chemotherapy... [Pg.1471]

NEUPOGEN Filgrastim (G-CSF) Amgen Chemotherapy-induced neutropenia, bone marrow transplantation, chronic severe neutropenia, peripheral blood progenitor cell transplant... [Pg.694]

Neupogen (filgrastim) Solution for IV or SC injection in single-use vial 2-8°C, do not freeze or shake do not leave at room temperature for longer than 6 hr Each mL 300 ug filgrastim, 0.59 mg acetate, 50 mg mannitol, 0.004% Tween 80... [Pg.709]

Neupogen (filgrastim G-CSF) Neutropenia caused by chemotherapy Bone marrow transplants Amgen Inc. [Pg.266]

Commonly reported side effects include bone and muscle pain. Serious (sometimes life threatening) but rare side effects have included splenic rupture and adult respiratory distress syndrome. Neupogen is manufactured and marketed by Amgen Inc. [Pg.272]

Network polymerization, in silicate and phosphate glasses, 12 574 Neuberg, Carl, 11 8 Neupogen, 3 817 Neural networks, 7 507... [Pg.616]

Neupogen), a four-helix bundle cytokine, is formulated at pH 4 but has been shown to maintain both thermal stability and tertiary structure at pH 2.60 In fact, the secondary structure of this molecule was shown to remain highly helical at pH 4 (Tm approximately 62°C) and 2 (Tm approximately 63°C) as compared to pH 7 (Tm approximately 55°C) where a less conformationally stable form was observed. In the same study, FTIR and CD data corroborated the tendency of the protein to unfold as measured by the loss of helical structure in the order pH 7 > pH 4 > pH 2. Moreover, after determining optimal pH conditions of thermostability, several studies have shown that excipient screening at such conditions can successfully predict the rank of formulation cocktails that offer the most favorable stability.14 23 31 56... [Pg.344]

G-CSF (granulocyte colony-stimulating factor) Nentropenia (low level of nentrophils leading to snsceptibihty to infections) Neulasta, Neupogen... [Pg.96]

Granulocyte colony-stimulating factor (G-CSF) (Neupogen 48 Mio U, F.Hoffmann-La Roche, Switzerland) was dissolved in 0,85% NaCl with 0,1% bovine serum albumin (Sigma) and was injected subcutaneously (25 pg/kg in 0,2 ml of 0,85% NaCl) once a day for 4 days. White blood cells (WBC) count and the hemogram of the peripheral blood were analyzed before and one day after each course. Seven courses were performed during half-year. [Pg.56]

Neosporin Maximum Strength 78 Neosporin Plus 78 Neosynephrine 56 Neupogen 35 Neuromin 38 Neutraphos 56 Nevirapine 51 Niadn 51... [Pg.81]

A), 3.8 billion Amgen s white blood cell stimulant, Neupogen (filgrastim), 3.0 billion interferon pia (Avonex for multiple sclerosis), 2.2 billion human growth hormone (HGH), 1.8 billion recombinant hepatitis B vaccine ( 1.0 billion) somatropin (Humatrope and Neutropin), 0.9 billion and cerezyme/ceredase (alglucerase), 0.6 billion. [Pg.620]

Filgrastim [G-CSF] (Neupogen) Oprelvekin (Neumega) Pegfilgrastim (Neulasta)... [Pg.50]

Neupogen (Amgen) Colony stimulating factor (treatment of neutropenia) 1.2... [Pg.11]

Neupogen (Filgrastim, rG-CSF differs from human protein by containing an additional N-terminal methionine. Produced in E. coli)... [Pg.502]

Neulasta (PEGfilgrastim, rPEGyl-ated filgrastim — see Neupogen). Also marketed in EU as Neupopeg... [Pg.502]

Dmg interactions Drug interactions between Neupogen and other drugs have not been fully evaluated. Drugs that may potentiate the release of neutrophils from bone marrow, such as lithium, should be used with caution. [Pg.139]


See other pages where Neupogen is mentioned: [Pg.42]    [Pg.411]    [Pg.1450]    [Pg.80]    [Pg.81]    [Pg.162]    [Pg.185]    [Pg.268]    [Pg.7]    [Pg.272]    [Pg.272]    [Pg.146]    [Pg.405]    [Pg.354]    [Pg.213]    [Pg.25]    [Pg.165]    [Pg.73]    [Pg.177]    [Pg.10]    [Pg.639]    [Pg.653]    [Pg.7]    [Pg.26]    [Pg.27]    [Pg.27]    [Pg.138]    [Pg.138]    [Pg.139]    [Pg.139]   
See also in sourсe #XX -- [ Pg.7 , Pg.27 , Pg.266 , Pg.475 ]

See also in sourсe #XX -- [ Pg.213 ]

See also in sourсe #XX -- [ Pg.165 ]

See also in sourсe #XX -- [ Pg.11 , Pg.502 ]

See also in sourсe #XX -- [ Pg.26 , Pg.138 , Pg.139 ]

See also in sourсe #XX -- [ Pg.165 ]

See also in sourсe #XX -- [ Pg.402 ]

See also in sourсe #XX -- [ Pg.57 ]

See also in sourсe #XX -- [ Pg.1624 , Pg.1629 ]

See also in sourсe #XX -- [ Pg.3 , Pg.263 ]

See also in sourсe #XX -- [ Pg.271 , Pg.275 ]

See also in sourсe #XX -- [ Pg.38 ]

See also in sourсe #XX -- [ Pg.931 ]

See also in sourсe #XX -- [ Pg.165 ]

See also in sourсe #XX -- [ Pg.84 ]

See also in sourсe #XX -- [ Pg.278 , Pg.290 ]

See also in sourсe #XX -- [ Pg.72 ]




SEARCH



Colony stimulating factors Neupogen

© 2024 chempedia.info